A new drug designed to counter the effects of an important, but very hard to target, cancer mutation could be effective against a range of tumour types including lung and gynaecological cancers, a new clinical trial shows.

The first patient has been treated, as part of a clinical trial, with an innovative new technology called Acoustic Cluster Therapy that uses microscopic clusters of bubbles and liquid droplets to enhance the delivery of chemotherapy drugs to tumours. The new therapy could improve targeting of chemotherapy and reduce doses.

Members of the The Discovery Club gathered at the Royal Society of Chemistry last month to learn how our research is influencing the cancer patient journey.